Pricing a new drug / Supriya Munshaw, Amarpreet Chawla.

Format:

Book

Author/Creator:

Munshaw, Supriya, author.

Chawla, Amarpreet, author.

Series:

SAGE Knowledge. Cases.

SAGE research methods. Cases.

SAGE Knowledge. Cases

SAGE research methods. Cases

Language:

English

Subjects (All):

Drugs--Prices--Case studies.

Drugs.

Pharmaceutical industry--Management.

Pharmaceutical industry.

Prescription pricing.

Exodus Pharmaceuticals, Inc.

Drugs--Prices.

Genre:

Case studies.

Physical Description:

1 online resource : illustrations.

Place of Publication:

London : SAGE Publications: SAGE Business Cases Originals, 2019.

System Details:

text file

Summary:

Exodus Pharmaceuticals, Inc. is a small pharmaceutical company with three pharmaceutical products on the market. A promising drug in late-stage clinical trials presents an opportunity for a comprehensive market access strategy including pricing and reimbursement. Rising launch prices of drugs are often cited as the primary reason for increasing U.S. prescription drug spending, making it essential to develop an evidence-based price. In this case study, students will explore how tethering the price of the drug to its value can result in optimal pricing. In doing so, students will be introduced to the concept of value-based pricing strategy and will determine the value and corresponding price of the drug as it relates to the key stakeholders, namely, patients, physicians, providers, and payers.

Notes:

Includes bibliographical references and index.

No ILL or scholarly sharing allowed.

Description based on XML content.

ISBN:

9781526498601

OCLC:

1098734674

Access Restriction:

Restricted for use by site license.